Discoidin domain receptor 2 is a critical regulator of epithelial-mesenchymal transition.

Discoidin domain receptor 2 (DDR2) is a collagen receptor that is expressed during epithelial-mesenchymal transition (EMT), a cellular transformation that mediates many stages of embryonic development and disease. However, the functional significance of this receptor in EMT is unknown. Here we show that Transforming Growth Factor-beta1 (TGF-β1), a common stimulator of EMT, promotes increased expression of type I collagen and DDR2. Inhibiting expression of COL1A1 or DDR2 with siRNA is sufficient to perturb activity of the NF-κB and LEF-1 transcription factors and to inhibit EMT and cell migration induced by TGF-β1. Furthermore, knockdown of DDR2 expression with siRNA inhibits EMT directly induced by type I collagen. These data establish a critical role for type I collagen-dependent DDR2 signaling in the regulation of EMT.

[1]  Jiri Zavadil,et al.  TGF-β and epithelial-to-mesenchymal transitions , 2005, Oncogene.

[2]  E. Goldsmith,et al.  The Collagen Receptor DDR2 Is Expressed During Early Cardiac Development , 2010, Anatomical record.

[3]  G. Adler,et al.  Down-regulation of E-cadherin gene expression by collagen type I and type III in pancreatic cancer cell lines. , 2001, Cancer research.

[4]  E. Hohenester,et al.  Crystallographic Insight into Collagen Recognition by Discoidin Domain Receptor 2 , 2009, Structure.

[5]  J. Thiery.  Epithelial–mesenchymal transitions in tumour progression , 2002, Nature Reviews Cancer.

[6]  C. Gilles,et al.  Implication of collagen type I-induced membrane-type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in the metastatic progression of breast carcinoma. , 1997, Laboratory investigation; a journal of technical methods and pathology.

[7]  G. Jarai,et al.  Epithelial-mesenchymal transition in primary human bronchial epithelial cells is Smad-dependent and enhanced by fibronectin and TNF-α , 2010, Fibrogenesis & tissue repair.

[8]  R. Mason,et al.  TGF-β1 induces human alveolar epithelial to mesenchymal cell transition (EMT) , 2005, Respiratory research.

[9]  T. Kawaguchi,et al.  Switching in discoid domain receptor expressions in SLUG‐induced epithelial‐mesenchymal transition , 2008, Cancer.

[10]  E. Hay,et al.  Cooperation between snail and LEF-1 transcription factors is essential for TGF-beta1-induced epithelial-mesenchymal transition. , 2006, Molecular biology of the cell.

[11]  E. Hay,et al.  TGFβ3 inhibits E-cadherin gene expression in palate medial-edge epithelial cells through a Smad2-Smad4-LEF1 transcription complex , 2007, Journal of Cell Science.

[12]  A. Kwan,et al.  The discoidin domain receptor DDR2 is a receptor for type X collagen. , 2006, Matrix biology : journal of the International Society for Matrix Biology.

[13]  Lin Xu,et al.  Attenuation of osteoarthritis progression by reduction of discoidin domain receptor 2 in mice. , 2010, Arthritis and rheumatism.

[14]  E. Hay.  An overview of epithelio-mesenchymal transformation. , 1995, Acta anatomica.

[15]  E. Fuchs,et al.  Links between signal transduction, transcription and adhesion in epithelial bud development , 2003, Nature.

[16]  L. Coussens,et al.  The tumor microenvironment: a critical determinant of neoplastic evolution. , 2003, European journal of cell biology.

[17]  B. Olsen,et al.  Snail and Slug promote epithelial-mesenchymal transition through beta-catenin-T-cell factor-4-dependent expression of transforming growth factor-beta3. , 2008, Molecular biology of the cell.

[18]  A. Nawshad,et al.  Type I collagen promotes epithelial-mesenchymal transition through ILK-dependent activation of NF-kappaB and LEF-1. , 2010, Matrix biology : journal of the International Society for Matrix Biology.

[19]  T. Gress,et al.  Collagen type I-induced Smad-interacting protein 1 expression downregulates E-cadherin in pancreatic cancer , 2007, Oncogene.

[20]  G. Adler,et al.  Collagen type I induces disruption of E-cadherin-mediated cell-cell contacts and promotes proliferation of pancreatic carcinoma cells. , 2006, Cancer research.

[21]  R. Derynck,et al.  TGF-β signaling in cancer – a double-edged sword , 2001 .

[22]  R. Kalluri,et al.  Epithelial-mesenchymal transition and its implications for fibrosis. , 2003, The Journal of clinical investigation.

[23]  Y. Shintani,et al.  Collagen I promotes epithelial-to-mesenchymal transition in lung cancer cells via transforming growth factor-beta signaling. , 2008, American journal of respiratory cell and molecular biology.

[24]  E. Hay,et al.  Transformations between epithelium and mesenchyme: normal, pathological, and experimentally induced. , 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[25]  Raghu Kalluri,et al.  The basics of epithelial-mesenchymal transition. , 2009, The Journal of clinical investigation.

[26]  B. Olsen,et al.  The mechanism of palatal clefting in the Col11a1 mutant mouse. , 2001, Archives of oral biology.

[27]  J. Fitzpatrick,et al.  TGF-beta1-induced EMT can occur independently of its proapoptotic effects and is aided by EGF receptor activation. , 2006, American journal of physiology. Renal physiology.